<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Invasive pneumococcal (Streptococcus pneumoniae) infections and bacteremia in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Invasive pneumococcal (Streptococcus pneumoniae) infections and bacteremia in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Invasive pneumococcal (Streptococcus pneumoniae) infections and bacteremia in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel M Musher, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Thomas M File, Jr, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Milana Bogorodskaya, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 13, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2948256313"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span><em>Streptococcus pneumoniae</em> (pneumococcus) has long been one of the most prominent bacterial causes of disease in humans and was one of the first to be identified as a cause of human infection [<a href="#rid1">1</a>]. Since 2000, however, its impact has been blunted by the widespread use of vaccines that largely prevent infection and colonization in young children.</p><p>This topic will discuss the epidemiology, risk factors, clinical syndromes, and the general principles of treatment of invasive pneumococcal disease in adults. Microbiology and pathogenesis of <em>Streptococcus pneumoniae</em> are discussed separately (see  <a class="medical medical_review" href="/d/html/7023.html" rel="external">"<i>Streptococcus pneumoniae</i>: Microbiology and pathogenesis of infection"</a>). Treatment considerations specific to the site of infection (eg, pneumonia, meningitis, endocarditis, septic arthritis) are discussed in detail elsewhere (see  <a class="medical medical_review" href="/d/html/7027.html" rel="external">"Treatment of community-acquired pneumonia in adults who require hospitalization", section on 'Patients who respond to therapy'</a> and  <a class="medical medical_review" href="/d/html/1283.html" rel="external">"Treatment of bacterial meningitis caused by specific pathogens in adults", section on 'Streptococcus pneumoniae'</a> and  <a class="medical medical_review" href="/d/html/2152.html" rel="external">"Antimicrobial therapy of left-sided native valve endocarditis", section on 'Streptococcus pneumoniae'</a> and  <a class="medical medical_review" href="/d/html/7666.html" rel="external">"Septic arthritis in adults", section on 'Treatment'</a>). Vaccination against pneumococcal disease in adults and children are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/7021.html" rel="external">"Pneumococcal vaccination in adults"</a> and  <a class="medical medical_review" href="/d/html/6053.html" rel="external">"Pneumococcal vaccination in children"</a> and  <a class="medical medical_review" href="/d/html/85526.html" rel="external">"Pneumococcal immunization in adults with HIV"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span><em>S. pneumoniae</em> is strictly a human pathogen, although animal models have been created to study the disease. Some genetic features have been associated with susceptibility to invasive pneumococcal disease (IPD), but the mechanism(s) underlying the association remain unknown [<a href="#rid2">2</a>].</p><p>A single nasopharyngeal culture shows about 20 to 25 percent of children in the United States to be colonized; with repeated sampling, the prevalence rises to 30 to 40 percent and, in daycare settings, it exceeds 50 percent [<a href="#rid3">3</a>]. On any single occasion, about 5 to 10 percent of adults are colonized; these rates have not changed substantially since introduction of the conjugate polysaccharide pneumococcal vaccine [<a href="#rid4">4</a>]. As might be expected, the rate of colonization is greater in parents of young children and lower in adults who have no exposure to children.</p><p>IPD in adults occurs more frequently from October through March than in May, June, or September and is rare in July and August [<a href="#rid5">5,6</a>]. The mechanism behind this seasonal variation remains unknown. </p><p class="headingAnchor" id="H1367251839"><span class="h1">RISK FACTORS FOR INVASIVE DISEASE</span><span class="headingEndMark"> — </span>There are many risk factors for invasive pneumococcal disease (IPD). The most important risk factors are discussed below  (<a class="graphic graphic_table graphicRef141040" href="/d/graphic/141040.html" rel="external">table 1</a>). </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Effect of colonization </strong>– Colonization, a condition in which pneumococci persist on mucosal surfaces in the upper respiratory tract without causing symptoms, is an actively immunizing process. Dendritic cells take in and process pneumococcal antigens and then present them to appropriate B cells. Within a few weeks of becoming colonized by pneumococci, healthy children [<a href="#rid7">7</a>] and adults [<a href="#rid8">8</a>] develop antibodies to the capsular polysaccharide. When invasive disease occurs, it is most likely to do so in the time between colonization and appearance of antibodies. Persons who have diminished capacity to produce antibodies to capsular polysaccharides remain susceptible while they are colonized. Conditions that affect the ability to mount an antibody response to <em>S. pneumoniae </em>are listed in the table  (<a class="graphic graphic_table graphicRef141040" href="/d/graphic/141040.html" rel="external">table 1</a>). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Effect of age </strong>– In adults, the incidence of and mortality from IPD increases with advancing age  (<a class="graphic graphic_figure graphicRef141038" href="/d/graphic/141038.html" rel="external">figure 1</a>). The figure shows the incidence by age in the pre-antibiotic era [<a href="#rid9">9</a>], the late 1980s (before introduction of conjugate pneumococcal vaccine [<a href="#rid10">10</a>]), and after the widespread use of 7-valent pneumococcal conjugate vaccine and introduction of 13-valent conjugate vaccine [<a href="#rid11">11</a>]. Note, in each case, the change in the vertical scale, which shows a steady decline, since the 1980s, in the overall frequency of IPD in the population. </p><p></p><p class="bulletIndent1">Levels and quality of antibody to capsular polysaccharides diminish with aging. With increased age, vaccinated persons produce lower levels of IgG, and the antibody has diminished effectiveness as an opsonizing agent [<a href="#rid12">12,13</a>]. These principles were illustrated in a remarkable case-control study showing that, with aging, the protective efficacy of <a class="drug drug_general" data-topicid="9784" href="/d/drug information/9784.html" rel="external">pneumococcal polysaccharide vaccine</a> (PPSV) was lower and declined more rapidly with time from vaccination, such that almost no protection was demonstrated in adults over 80 years of age [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Effect of race and ethnicity</strong> – In the United States, IPD is more common in self-identified Black people [<a href="#rid15">15-17</a>] and Native Americans [<a href="#rid18">18-20</a>] than in persons who identify as part of the White population. Although socioeconomic factors [<a href="#rid15">15</a>] and comorbidities [<a href="#rid18">18</a>] certainly contribute [<a href="#rid21">21</a>], there is thought to be a distinct genetic basis, but the mechanism(s) underlying these predispositions is unknown.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Crowded living arrangements</strong> – Crowding, whether among miners in South Africa [<a href="#rid22">22</a>], soldiers in military barracks [<a href="#rid23">23,24</a>], prisoners [<a href="#rid25">25</a>], or persons living in homeless shelters [<a href="#rid26">26</a>], is highly associated with increased risk and even outbreaks of pneumococcal disease. The increased risk of IPD in some of these groups is striking; a population-based study from Toronto [<a href="#rid27">27</a>] showed a 30-fold increase in the risk of IPD among homeless persons compared with the population at large. It remains unknown what causes crowding to increase the risk of pneumococcal disease although several theories have been proposed. For example, some studies have found physical and emotional stress to be related to susceptibility to IPD among military recruits in the Second World War [<a href="#rid23">23,24</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immunocompromising conditions</strong> – Adults who acquire conditions that prevent them from making antibody to new antigens are at high risk for IPD  (<a class="graphic graphic_table graphicRef141040" href="/d/graphic/141040.html" rel="external">table 1</a>). Patients with multiple myeloma or lymphoma are especially unable to make antibody in response to polysaccharide antigens. IPD appears regularly in patients with untreated lymphoma or multiple myeloma and, in fact, often leads to the initial recognition of these conditions [<a href="#rid28">28,29</a>].</p><p></p><p class="bulletIndent1">An extensive literature has amply documented the susceptibility of patients with human immunodeficiency virus (HIV) to IPD. Early in the acquired immunodeficiency syndrome (AIDS) era, the incidence of bacteremic pneumococcal pneumonia was increased 200-fold over that in an age-matched population [<a href="#rid30">30</a>], and a more recent study of adults ages 18 to 64 years showed that the rate of IPD was 46 times greater among patients with AIDS than among those without known HIV infection [<a href="#rid16">16</a>]. Antiretroviral treatment reduces this risk but, despite such treatment, the incidence of IPD remains sevenfold greater in patients with HIV than in the general population [<a href="#rid31">31</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Comorbidities</strong> – Frailty and comorbid conditions probably contribute more to susceptibility to IPD than does simple chronologic age [<a href="#rid32">32</a>]. Chronic pulmonary disease is the most common condition that predisposes to IPD; other conditions are listed in the table  (<a class="graphic graphic_table graphicRef141040" href="/d/graphic/141040.html" rel="external">table 1</a>) [<a href="#rid33">33</a>]. Other individuals with abnormal polymorphonuclear function or conditions with multifactorial effects such as malnutrition, alcoholism, cirrhosis, and chronic renal disease are also susceptible to IPD.</p><p></p><p class="bulletIndent1">Diabetes mellitus is associated with IPD; in two population-based studies, the risk of IPD in people with diabetes was six times greater than that in the population at large [<a href="#rid17">17,34</a>]. Impaired function of polymorphonuclear leukocytes (PMNs) is likely responsible. However, in a homogeneous Danish population, the risk was increased but at a much lower rate [<a href="#rid35">35</a>]. A multicenter study found that diabetes was the only comorbid condition of many that were examined that was specifically associated with increased mortality from IPD in patients hospitalized in an intensive care unit [<a href="#rid36">36</a>]. It is not clear whether risk from diabetes remains if the diabetes is well controlled, although studies in vitro specifically show that diminished PMN function is specifically related to increased levels of glucose  (<a class="graphic graphic_table graphicRef141040" href="/d/graphic/141040.html" rel="external">table 1</a>).</p><p></p><p class="bulletIndent1">The strong association between alcohol ingestion and IPD has been noted since the beginning of the 20<sup>th</sup> century [<a href="#rid9">9</a>], and a &gt;10-fold risk of IPD in persons with alcohol abuse syndrome continues to the present time [<a href="#rid17">17</a>]. The broad range of adverse effects of alcohol on the immune system, from suppression of innate immunity to altered cytokine responses, have been examined in depth elsewhere [<a href="#rid37">37</a>].</p><p></p><p class="bulletIndent1">Hyposplenism is a major risk factor for IPD. Slow flow of blood through the sinusoids of Billroth enables clearance of bacteria, even encapsulated ones, in the absence of antibody. Splenectomy, hyposplenism, and poor splenic function because of hemoglobinopathy are all highly associated with overwhelming pneumococcal bacteremia [<a href="#rid38">38,39</a>].</p><p></p><p class="bulletIndent1">Systemic lupus erythematosus, even in the absence of corticosteroid therapy, also carries increased risk of IPD [<a href="#rid40">40</a>].</p><p></p><p class="headingAnchor" id="H3750373183"><span class="h1">CLINICAL SYNDROMES</span><span class="headingEndMark"> — </span>Most of the important observations on the manifestations of invasive pneumococcal disease (IPD) cited in this section are derived from the century of study that preceded the widespread use of pneumococcal vaccine. </p><p class="headingAnchor" id="H281003848"><span class="h2">Spectrum of disease</span><span class="headingEndMark"> — </span>IPD is defined as infection in which <em>S. pneumoniae </em>is isolated from a normally sterile body site. Specific presentations of IPD to be discussed in this section are listed in the approximate order of decreasing frequency in the table  (<a class="graphic graphic_table graphicRef141041" href="/d/graphic/141041.html" rel="external">table 2</a>). </p><p>Bacteremic pneumococcal pneumonia with or without empyema is, by far, the most common presentation, followed by pneumococcal bacteremia in which no source is identified (termed "primary pneumococcal bacteremia"). Meningitis, septic arthritis, spontaneous peritonitis, osteomyelitis, endocarditis, and soft tissue infection are other major forms of IPD. </p><p class="headingAnchor" id="H3116462938"><span class="h2">Bacteremic pneumococcal pneumonia and empyema</span><span class="headingEndMark"> — </span>Pneumonia is the most common source of IPD, identified in 65 to 85 percent of invasive pneumococcal cases [<a href="#rid6">6,41,42</a>]. Presumptive pneumococcal pneumonia is the isolation of <em>S. pneumoniae</em> only from sputum. Proven pneumococcal pneumonia requires isolation of <em>S. pneumoniae </em>from either the blood or another normally sterile body site. </p><p>Bacteremia is documented in about 20 to 25 percent of cases of pneumococcal pneumonia [<a href="#rid9">9,43</a>]. Patients with positive blood cultures tend to be younger, present with a shorter period of illness, and have a higher likelihood of severe disease including septic shock, in-hospital mortality, and 30-day mortality [<a href="#rid44">44-46</a>]. In bacteremic individuals, the mortality is proportional to the initial severity of infection [<a href="#rid47">47</a>], and the risk has been shown to persist for 10 years [<a href="#rid47">47,48</a>]. (See <a class="local">'Prognosis and prevention'</a> below.)</p><p>Patients with bacteremic pneumococcal pneumonia often present with a dense lobar consolidation [<a href="#rid44">44,49,50</a>], and white blood cell (WBC) counts &lt;6000 or &gt;25,000 are associated with five- and threefold greater mortality, respectively [<a href="#rid51">51</a>]. </p><p>Empyema occurs in about 5 percent of patients with bacteremic pneumococcal pneumonia. Organisms may reach the pleural space either by extension of pneumonia to the visceral pleura or by bacteremia with pneumococci settling in an area of compromised immunity (pneumococcal peritonitis). We evaluate for empyema in every patient with invasive pneumococcal pneumonia who does not respond to antibiotic therapy within a few days [<a href="#rid9">9</a>]. (See  <a class="medical medical_review" href="/d/html/7013.html" rel="external">"Pneumococcal pneumonia in patients requiring hospitalization", section on 'Pleural effusion and empyema'</a>.)</p><p>The clinical manifestations, diagnosis, and treatment of bacteremic pneumococcal pneumonia are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/7013.html" rel="external">"Pneumococcal pneumonia in patients requiring hospitalization"</a>.)</p><p class="headingAnchor" id="H537241758"><span class="h2">Bacteremia of unknown source</span><span class="headingEndMark"> — </span>Bacteremia with no recognizable source, also known as primary bacteremia, has been reported in about 5 to 20 percent of cases of IPD. In these circumstances, we perform a thorough history and examination and tailor further diagnostic tests based on present symptoms or signs that may indicate another site of infection (eg, computed tomography [CT] of abdomen and pelvis for abdominal pain). (See <a class="local">'Further evaluation for other sites of infection'</a> below.) </p><p>In one intensive prospective study using more modern techniques, only 5.1 percent of patients with IPD had bacteremia of unknown source [<a href="#rid42">42</a>].</p><p class="headingAnchor" id="H644398125"><span class="h2">Meningitis</span><span class="headingEndMark"> — </span>In the absence of an outbreak of meningococcal meningitis, <em>S. pneumoniae </em>remains the most common cause of bacterial meningitis at all ages and in all groups of patients except neonates [<a href="#rid52">52,53</a>]. </p><p>No distinctive clinical features or findings in the cerebrospinal fluid (CSF) other than Gram stain and culture enable pneumococcal meningitis to be distinguished from that due to other bacterial causes. Blood cultures are usually, but not always, positive. CSF contains hundreds to thousands of WBCs per microL, the glucose level is very low (usually &lt;25 mg/dL), and the protein is likely to exceed 200 mg/dL. Before antibiotics are administered, large numbers of bacteria (&gt;10<sup>7</sup> per mL) are regularly present [<a href="#rid54">54</a>]. If lumbar puncture is done before or soon after antibiotics are begun, Gram stain of centrifuged CSF should lead to the correct diagnosis in &gt;95 percent of cases [<a href="#rid55">55</a>]. After 12 to 18 hours of antibiotics, pneumococci may no longer be cultured from CSF and the cell count and protein may be difficult to interpret, supporting the need for urgent spinal tap if meningitis is suspected.</p><p>Further details on epidemiology, clinical manifestations, diagnosis, management, and neurological complications of pneumococcal meningitis are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/1294.html" rel="external">"Epidemiology of community-acquired bacterial meningitis in adults"</a> and  <a class="medical medical_review" href="/d/html/1287.html" rel="external">"Clinical features and diagnosis of acute bacterial meningitis in adults"</a> and  <a class="medical medical_review" href="/d/html/1290.html" rel="external">"Initial therapy and prognosis of community-acquired bacterial meningitis in adults"</a> and  <a class="medical medical_review" href="/d/html/1283.html" rel="external">"Treatment of bacterial meningitis caused by specific pathogens in adults", section on 'Streptococcus pneumoniae'</a> and  <a class="medical medical_review" href="/d/html/1299.html" rel="external">"Dexamethasone to prevent neurologic complications of bacterial meningitis in adults"</a>.)</p><p class="headingAnchor" id="H202372132"><span class="h2">Pneumococcal peritonitis (intraabdominal infection)</span><span class="headingEndMark"> — </span>Pneumococcal peritonitis can be categorized into three broad categories: (1) peritonitis occurring in persons who had pre-existing ascites, (2) peritonitis following a gastric phlegmon or perforated viscus, or (3) peritonitis in females, occurring from ascent of pneumococci via the Fallopian tubes [<a href="#rid56">56</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Spontaneous bacterial peritonitis in patients with ascites </strong>–<strong> </strong>Spontaneous pneumococcal peritonitis in patients with pre-existing ascites occurs in both males and females. In persons who have pre-existing ascites, the peritoneal cavity serves as a compromised site (<em>locus minoris resistentiae</em>), and pneumococci lodge there during recognized or unrecognized bacteremia. This condition is called primary pneumococcal peritonitis. In the preantibiotic era, a small proportion of patients with pneumococcal pneumonia developed peritonitis as a complication; it is not certain whether all of these had pre-existing ascites. (See  <a class="medical medical_review" href="/d/html/1247.html" rel="external">"Spontaneous bacterial peritonitis in adults: Clinical manifestations"</a> and  <a class="medical medical_review" href="/d/html/1249.html" rel="external">"Spontaneous bacterial peritonitis in adults: Diagnosis"</a> and  <a class="medical medical_review" href="/d/html/1248.html" rel="external">"Spontaneous bacterial peritonitis in adults: Treatment and prophylaxis"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Peritonitis associated with perforation </strong>–<strong> </strong>Secondary pneumococcal peritonitis in males or females follows perforation of a viscus, such as a gastric or duodenal ulcer, acute appendicitis, or cholecystitis, or is associated with gastric phlegmon. Pathogenesis is presumed to be the ingestion of pneumococci in the absence of antibody. In some cases, the pathogenesis is simply obscure [<a href="#rid57">57</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Peritonitis associated with the female genital tract </strong>–<strong> </strong>In the absence of pre-existing ascites or perforation/infection of a viscus, pneumococcal peritonitis occurs almost exclusively in females; the pathogenesis in these cases is ascent via the female genital tract. In this third scenario, most cases occur post-partum, in association with an intrauterine device, or following a syndrome of pelvic inflammatory disease [<a href="#rid58">58-60</a>]. When pneumococcal peritonitis occurs in females with none of these known predisposing conditions, an unrecognized underlying infection of the genital tract is thought to be responsible, and patients should be evaluated for this. (See  <a class="medical medical_review" href="/d/html/5488.html" rel="external">"Postpartum endometritis"</a> and  <a class="medical medical_review" href="/d/html/5422.html" rel="external">"Intrauterine contraception: Management of side effects and complications"</a> and  <a class="medical medical_review" href="/d/html/7581.html" rel="external">"Pelvic inflammatory disease: Clinical manifestations and diagnosis"</a>.) </p><p></p><p class="headingAnchor" id="H590440003"><span class="h2">Septic arthritis</span><span class="headingEndMark"> — </span>Septic arthritis occurs in about 1.5 percent of IPD cases, and <em>S. pneumoniae </em>is the third most common bacterial cause of septic arthritis [<a href="#rid61">61-63</a>]. Most adults with pneumococcal septic arthritis have predisposing rheumatologic conditions, such as rheumatoid arthritis, osteoarthritis, gout or pseudogout, and/or alcohol use disorder [<a href="#rid61">61,64</a>]. Although any large joint may be affected, the knee, alone or together with other joints, is involved in more than one-half of all cases, perhaps because of associated daily trauma. Prosthetic knee joints are also susceptible to pneumococcal infection [<a href="#rid65">65</a>]. Polyarthritis, detected in 56 percent of cases, is more common in pneumococcal septic arthritis than in that due to other bacteria, perhaps related to the high proportion (70 percent) of patients who have documented bacteremia. Primary bacteremia or endocarditis rather than pneumonia is often the cause of pneumococcal arthritis or osteomyelitis [<a href="#rid42">42,66</a>]. </p><p class="headingAnchor" id="H1491053354"><span class="h2">Endocarditis</span><span class="headingEndMark"> — </span>Pneumococcal endocarditis occurs rarely with one or two cases being seen each decade in large tertiary care hospitals; 16 cases were documented in the entire country of Denmark during a 12-year period [<a href="#rid42">42,67,68</a>]. The disease has a particularly high association with alcohol abuse syndrome. The majority of cases follow pneumonia and involve previously normal valves, although previously diseased or prosthetic valves may also be infected. Pneumococcal endocarditis is usually fulminant with a high rate of embolic complications, perforation, and need for valve replacement. Often, infection is present at multiple body sites. Of 30 patients with pneumococcal endocarditis, 10 underwent spinal tap, of whom 9 had findings consistent with meningitis. (See  <a class="medical medical_review" href="/d/html/2152.html" rel="external">"Antimicrobial therapy of left-sided native valve endocarditis", section on 'Streptococcus pneumoniae'</a> and  <a class="medical medical_review" href="/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"</a> and  <a class="medical medical_review" href="/d/html/2149.html" rel="external">"Right-sided native valve infective endocarditis"</a> and  <a class="medical medical_review" href="/d/html/2151.html" rel="external">"Native valve endocarditis: Epidemiology, risk factors, and microbiology"</a>.)</p><p class="headingAnchor" id="H2238661890"><span class="h2">Austrian syndrome</span><span class="headingEndMark"> — </span>Robert Austrian, an American expert on <em>S. pneumoniae</em>, described eight patients, seen between 1946 and 1954, who had pneumococcal endocarditis, pneumonia, and meningitis [<a href="#rid2">2</a>]. Originally called Osler's triad, this syndrome was renamed to honor Dr. Austrian. In more recent years, the syndrome occurs infrequently but remains lethal in many cases.</p><p class="headingAnchor" id="H637306981"><span class="h2">Pericarditis</span><span class="headingEndMark"> — </span>Pneumococcal pericarditis has been described only rarely in the antibiotic era [<a href="#rid69">69</a>], although this condition occurred more frequently with pneumococcal pneumonia and especially as a complication of endocarditis in the preantibiotic era. The presentation may be as pericarditis or pericarditis with tamponade [<a href="#rid70">70</a>]. (See  <a class="medical medical_review" href="/d/html/4957.html" rel="external">"Etiology of pericardial disease", section on 'Bacterial'</a> and  <a class="medical medical_review" href="/d/html/4940.html" rel="external">"Acute pericarditis: Clinical presentation and diagnosis"</a>.) </p><p class="headingAnchor" id="H3262322641"><span class="h2">Miscellaneous infections</span><span class="headingEndMark"> — </span>Pneumococcal osteomyelitis in adults tends to involve the vertebral bodies [<a href="#rid66">66,71</a>]. Spinal epidural abscess was reported as a complication in one-half of cases [<a href="#rid66">66</a>]. Brain abscesses have been rare in the antibiotic era [<a href="#rid72">72</a>]. Soft tissue infections may occur in persons who have connective tissue diseases or HIV infection [<a href="#rid73">73,74</a>]. Bacteremia leading to cellulitis has been described as a complication of pneumonia, generally occurring in patients who have severe underlying diseases [<a href="#rid75">75</a>].</p><p class="headingAnchor" id="H3598962432"><span class="h1">DIAGNOSTIC EVALUATION</span></p><p class="headingAnchor" id="H3569824998"><span class="h2">When to suspect IPD</span><span class="headingEndMark"> — </span>Clinically, infections due to invasive pneumococcal disease (IPD) cannot be distinguished from those due to other bacterial pathogens that cause similar infectious syndromes. Nevertheless, IPD should be considered in patients presenting with sepsis without an apparent focus of infection, especially those who have underlying susceptibility to infection by encapsulated organisms such as patients without a functional spleen. Austrian syndrome should be suspected if a patient presents with respiratory and meningeal symptoms, and/or evidence of endocarditis. </p><p class="headingAnchor" id="H462852893"><span class="h2">Establishing the diagnosis</span><span class="headingEndMark"> — </span><em>S. pneumoniae</em> should always be considered a true pathogen when isolated from a sterile body site. The bacteria can be identified using routine, phenotype-based culture systems (see  <a class="medical medical_review" href="/d/html/7023.html" rel="external">"<i>Streptococcus pneumoniae</i>: Microbiology and pathogenesis of infection", section on 'Microbiology'</a>). Although urinary antigen detection is helpful in the diagnosis of pneumococcal pneumonia, its sensitivity for detecting pneumococcal invasive infection in the absence of pneumonia is around 60 percent [<a href="#rid76">76</a>]. Pneumococcal blood polymerase chain reaction (PCR) testing shows promise for detecting IPD but larger, more robust studies are needed prior to widespread clinical use [<a href="#rid77">77,78</a>]. </p><p class="headingAnchor" id="H2596657637"><span class="h1">POST-DIAGNOSTIC EVALUATION</span></p><p class="headingAnchor" id="H3829453710"><span class="h2">Evaluation for underlying immunocompromise</span><span class="headingEndMark"> — </span>In patients with invasive pneumococcal disease (IPD) without evident risk factors for invasive disease (eg, extremes of age, immunocompromising condition), we send HIV testing and immunoglobulin level testing to evaluate for immunocompromise.</p><p class="headingAnchor" id="H411744118"><span class="h2">Further evaluation for other sites of infection</span><span class="headingEndMark"> — </span>Some patients develop pneumococcal infection at multiple sites throughout the course of infection. After diagnosis of IPD, we tailor further workup based on the patient's symptoms. We only perform a lumbar puncture if there is suspicion of meningitis based on the patient's mental status and other clinical neurological signs. Similarly, since pneumococcal endocarditis is rare, we do not perform transthoracic echocardiography in all patients with IPD; instead, we choose to proceed with transthoracic echocardiogram (TTE) in select cases where bacteremia is persistent (≥3 days), there is presence of a new heart murmur, and/or there is evidence of endocarditis stigmata. </p><p class="headingAnchor" id="H1769738257"><span class="h1">TREATMENT</span></p><p class="headingAnchor" id="H3240896362"><span class="h2">Overview</span><span class="headingEndMark"> — </span>The goal of treatment is the eradication of infection. Treatment of invasive pneumococcal disease (IPD) consists of appropriate antibiotic treatment and drainage/debridement, when applicable. </p><p>Treatment of pneumococcal pneumonia, meningitis, and endocarditis is discussed separately. (See  <a class="medical medical_review" href="/d/html/7013.html" rel="external">"Pneumococcal pneumonia in patients requiring hospitalization", section on 'Treatment'</a> and  <a class="medical medical_review" href="/d/html/1283.html" rel="external">"Treatment of bacterial meningitis caused by specific pathogens in adults", section on 'Streptococcus pneumoniae'</a> and  <a class="medical medical_review" href="/d/html/2152.html" rel="external">"Antimicrobial therapy of left-sided native valve endocarditis", section on 'Streptococcus pneumoniae'</a>.) </p><p>Management of individual infections (eg, osteomyelitis, septic arthritis) is discussed in topics on each respective syndrome. (See  <a class="medical medical_review" href="/d/html/7666.html" rel="external">"Septic arthritis in adults", section on 'Treatment'</a> and  <a class="medical medical_review" href="/d/html/114350.html" rel="external">"Nonvertebral osteomyelitis in adults: Treatment"</a> and  <a class="medical medical_review" href="/d/html/7663.html" rel="external">"Vertebral osteomyelitis and discitis in adults", section on 'Treatment'</a> and  <a class="medical medical_review" href="/d/html/1248.html" rel="external">"Spontaneous bacterial peritonitis in adults: Treatment and prophylaxis", section on 'Treatment'</a> and  <a class="medical medical_review" href="/d/html/2128.html" rel="external">"Purulent pericarditis", section on 'Treatment'</a>.)</p><p class="headingAnchor" id="H1927384390"><span class="h2">Antibiotic selection for nonmeningeal disease</span><span class="headingEndMark"> — </span>Beta-lactam antibiotics are the mainstay of treatment. Although <em>S. pneumoniae </em>is not as susceptible to penicillin as it was in the preantibiotic era  (<a class="graphic graphic_table graphicRef63881" href="/d/graphic/63881.html" rel="external">table 3</a>), beta-lactamase production has not been described, and the parenteral doses of penicillin, <a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a>, and <a class="drug drug_general" data-topicid="9229" href="/d/drug information/9229.html" rel="external">ceftriaxone</a> that are ordinarily prescribed provide effective therapeutic levels in nearly all cases of IPD. </p><p>For patients with a beta-lactam allergy, the severity and characteristics of the allergy should be assessed to determine whether the patient can receive penicillins, cephalosporins, or carbapenems (see  <a class="medical medical_review" href="/d/html/111361.html" rel="external">"Choice of antibiotics in penicillin-allergic hospitalized patients"</a>). For patients with serious penicillin allergies, carbapenems, fluoroquinolones, <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a>, and <a class="drug drug_general" data-topicid="10283" href="/d/drug information/10283.html" rel="external">linezolid</a> are reasonable alternatives for treatment of IPD.</p><p>The susceptibility of pneumococci to various antibiotics is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/7034.html" rel="external">"Resistance of <i>Streptococcus pneumoniae</i> to beta-lactam antibiotics"</a> and  <a class="medical medical_review" href="/d/html/7033.html" rel="external">"Resistance of <i>Streptococcus pneumoniae</i> to the macrolides, azalides, and lincosamides"</a> and  <a class="medical medical_review" href="/d/html/7028.html" rel="external">"Resistance of <i>Streptococcus pneumoniae</i> to the fluoroquinolones, doxycycline, and trimethoprim-sulfamethoxazole"</a>.) </p><p class="headingAnchor" id="H797581130"><span class="h3">Initial antibiotic regimen</span><span class="headingEndMark"> — </span>Patients with IPD warrant initial treatment with intravenous or highly bioavailable oral antibiotics until they are clinically stable. We suggest <a class="drug drug_general" data-topicid="9229" href="/d/drug information/9229.html" rel="external">ceftriaxone</a> 1 to 2 g intravenously every 24 hours (1 g every 12 hours is preferred if the penicillin minimal inhibitory concentration [MIC] is ≥4 or unknown  (<a class="graphic graphic_table graphicRef63881" href="/d/graphic/63881.html" rel="external">table 3</a>)) due to its excellent efficacy, ease of dosing, and affordability. </p><p><a class="drug drug_general" data-topicid="9749" href="/d/drug information/9749.html" rel="external">Penicillin G</a> 2 million units intravenously every 4 hours (only if MIC &lt;2 mcg/mL  (<a class="graphic graphic_table graphicRef63881" href="/d/graphic/63881.html" rel="external">table 3</a>)) is also a reasonable option. </p><p>Alternative options for patients who cannot tolerate penicillins or cephalosporins include: </p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9554" href="/d/drug information/9554.html" rel="external">Levofloxacin</a> 750 mg intravenously or orally every 24 hours </p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10311" href="/d/drug information/10311.html" rel="external">Moxifloxacin</a> 400 mg intravenously or orally every 24 hours </p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">Vancomycin</a> intravenously  (<a class="graphic graphic_table graphicRef128911" href="/d/graphic/128911.html" rel="external">table 4</a> and <a class="graphic graphic_table graphicRef60466" href="/d/graphic/60466.html" rel="external">table 5</a>)</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10283" href="/d/drug information/10283.html" rel="external">Linezolid</a> 600 mg intravenously or orally every 12 hours</p><p></p><p>Pneumococcal susceptibility to the alternative agents used should be confirmed with the microbiology laboratory. </p><p class="headingAnchor" id="H472031997"><span class="h3">Oral step-down regimens in select cases</span><span class="headingEndMark"> — </span>After the first few doses in a stable patient, there is no need to give antibiotics intravenously except in endovascular (eg, endocarditis) infections or meningitis and rare cases in which a particularly high MIC mandates it  (<a class="graphic graphic_table graphicRef63881" href="/d/graphic/63881.html" rel="external">table 3</a>) [<a href="#rid79">79</a>]. Oral step-down regimens (once microbiological susceptibility is confirmed) include: </p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">Amoxicillin</a> 1 g every 8 hours (only if MIC &lt;2 mcg/mL  (<a class="graphic graphic_table graphicRef63881" href="/d/graphic/63881.html" rel="external">table 3</a>))</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9230" href="/d/drug information/9230.html" rel="external">Cefuroxime</a> axetil 500 mg orally every 12 hours </p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9554" href="/d/drug information/9554.html" rel="external">Levofloxacin</a> 750 mg orally every 24 hours </p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10311" href="/d/drug information/10311.html" rel="external">Moxifloxacin</a> 400 mg orally every 24 hours</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10283" href="/d/drug information/10283.html" rel="external">Linezolid</a> 600 mg orally every 12 hours</p><p></p><p class="headingAnchor" id="H3224543670"><span class="h2">Duration of therapy</span><span class="headingEndMark"> — </span>The duration of therapy depends on the underlying site of infection. In general, antimicrobial therapy should be administered until clinical signs of infection have resolved and as recommended for the site of infection. </p><p>The duration of treatment for primary pneumococcal bacteremia remains unclear. In the absence of good data, we prefer to treat bacteremic pneumococcal pneumonia for five to seven days and isolated bacteremia without evidence of pneumonia for 8 to 10 days. </p><p class="headingAnchor" id="H4098502569"><span class="h1">PROGNOSIS AND PREVENTION</span><span class="headingEndMark"> — </span>The estimated case fatality rate for pneumococcal bacteremia among adults is around 20 to 30 percent [<a href="#rid80">80-85</a>] and can be as high as 60 percent in patients with certain factors, such as older age or the presence of comorbid conditions (eg, asplenia or immunocompromising conditions, alcohol abuse)  (<a class="graphic graphic_figure graphicRef138890" href="/d/graphic/138890.html" rel="external">figure 2</a>). The degree of severity of infection and the pneumococcal serotype causing the infection also affect the mortality rate. For patients that do survive, long-lasting morbidity can be a problem. An increased rate of death persists for up to 10 years after pneumococcal bacteremia [<a href="#rid47">47</a>]; lasting epigenetic changes may be responsible [<a href="#rid86">86</a>]. For pneumococcal septic arthritis, many patients are left with residual dysfunction in the joint [<a href="#rid87">87</a>]. </p><p>Vaccination is the most effective means of preventing pneumococcal infection and is discussed separately (see  <a class="medical medical_review" href="/d/html/7021.html" rel="external">"Pneumococcal vaccination in adults"</a> and  <a class="medical medical_review" href="/d/html/85526.html" rel="external">"Pneumococcal immunization in adults with HIV"</a>). Other preventive measures include smoking cessation, limiting alcohol intake, and optimizing care of predisposing conditions, such as asthma or chronic obstructive pulmonary disease (COPD). </p><p class="headingAnchor" id="H1250541797"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/104226.html" rel="external">"Society guideline links: Community-acquired pneumonia in adults"</a> and  <a class="medical medical_society_guidelines" href="/d/html/104441.html" rel="external">"Society guideline links: Bacterial meningitis in adults"</a> and  <a class="medical medical_society_guidelines" href="/d/html/110423.html" rel="external">"Society guideline links: Bacterial meningitis in infants and children"</a> and  <a class="medical medical_society_guidelines" href="/d/html/110422.html" rel="external">"Society guideline links: Pneumococcal vaccination in adults"</a>.)</p><p class="headingAnchor" id="H12439041"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/16928.html" rel="external">"Patient education: Sepsis in adults (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H1791179507"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition of invasive pneumococcal disease </strong>– Invasive pneumococcal disease (IPD) refers to an infection caused by <em>S. pneumoniae </em>in a normally sterile body site, such as blood, cerebrospinal fluid (CSF), pleural fluid, synovial fluid, or pericardial fluid. (See <a class="local">'Introduction'</a> above and <a class="local">'Spectrum of disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology and risk factors</strong> – <em>S. pneumoniae</em> is strictly a human pathogen. Risk factors include colonization, extremes of age, frailty, race and ethnicity, crowded living arrangements, and immunocompromising conditions and other medical comorbidities  (<a class="graphic graphic_table graphicRef141040" href="/d/graphic/141040.html" rel="external">table 1</a>). (See <a class="local">'Epidemiology'</a> above and <a class="local">'Risk factors for invasive disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations </strong>– Bacteremic pneumococcal pneumonia with or without empyema is, by far, the most common presentation, followed by pneumococcal bacteremia in which no source is identified (termed "primary pneumococcal bacteremia")  (<a class="graphic graphic_table graphicRef141041" href="/d/graphic/141041.html" rel="external">table 2</a>). (See <a class="local">'Clinical syndromes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic evaluation</strong> – Clinically, invasive pneumococcal infections cannot be distinguished from other bacterial pathogens that cause similar infectious syndromes. <em>S. pneumoniae</em> should always be considered a true pathogen when isolated from a sterile body site. Pneumococcal urinary antigen and blood polymerase chain reaction (PCR) testing are not useful in the diagnosis of IPD. (See <a class="local">'Diagnostic evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Post-diagnostic evaluation</strong> – After establishing the diagnosis of IPD, further evaluation is dependent on the patient's symptoms and signs on physical exam. If the patient does not have any evident risk factors for IPD, we send HIV and immunoglobulin testing to evaluate for immunocompromise. (See <a class="local">'Post-diagnostic evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment </strong>– The goal of treatment is the eradication of infection via appropriate antibiotic treatment and drainage/debridement, when applicable. Beta-lactam antibiotics are the mainstay of treatment. For patients with serious allergic reactions to penicillins, alternatives include carbapenems, fluoroquinolones, <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a>, and <a class="drug drug_general" data-topicid="10283" href="/d/drug information/10283.html" rel="external">linezolid</a>. Pneumococcal susceptibility to the alternative agents used should be confirmed with the microbiology laboratory. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Initial intravenous regimen</strong> – We suggest <a class="drug drug_general" data-topicid="9229" href="/d/drug information/9229.html" rel="external">ceftriaxone</a> 1 to 2 g intravenously every 24 hours (1 g every 12 hours is preferred if the penicillin minimum inhibitory concentration [MIC] is ≥4 or unknown  (<a class="graphic graphic_table graphicRef63881" href="/d/graphic/63881.html" rel="external">table 3</a>)) due to its excellent efficacy, ease of dosing, and affordability (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Initial antibiotic regimen'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Oral step down regimens</strong> – After the first few doses in a stable patient, there is no need to give antibiotics intravenously except in endovascular (eg, endocarditis) and meningitis infections and rare cases in which a particularly high MIC mandates it  (<a class="graphic graphic_table graphicRef63881" href="/d/graphic/63881.html" rel="external">table 3</a>) (see <a class="local">'Oral step-down regimens in select cases'</a> above). Oral step-down regimens (when microbiologic susceptibility is confirmed) include: </p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">Amoxicillin</a> 1 g every 8 hours (only if MIC &lt;2 mcg/mL  (<a class="graphic graphic_table graphicRef63881" href="/d/graphic/63881.html" rel="external">table 3</a>))</p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="9230" href="/d/drug information/9230.html" rel="external">Cefuroxime</a> axetil 500 mg orally every 12 hours</p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="9554" href="/d/drug information/9554.html" rel="external">Levofloxacin</a> 750 mg orally every 24 hours </p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="10311" href="/d/drug information/10311.html" rel="external">Moxifloxacin</a> 400 mg orally every 24 hours </p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="10283" href="/d/drug information/10283.html" rel="external">Linezolid</a> 600 mg orally every 12 hours</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Duration of antibiotic therapy</strong> – The duration of therapy depends on the underlying site of infection. In general, antimicrobial therapy should be administered until clinical signs of infection have resolved and as recommended for the site of infection. (See <a class="local">'Duration of therapy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention </strong>– Pneumococcal vaccination is the most effective means of preventing IPD. Other preventive measures include smoking cessation and optimizing care of predisposing conditions such as asthma and chronic obstructive pulmonary disease (COPD). (See <a class="local">'Prognosis and prevention'</a> above and  <a class="medical medical_review" href="/d/html/7021.html" rel="external">"Pneumococcal vaccination in adults"</a> and  <a class="medical medical_review" href="/d/html/6053.html" rel="external">"Pneumococcal vaccination in children"</a>.)</p><p></p><p class="headingAnchor" id="H3830463402"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>UpToDate gratefully acknowledges John G Bartlett, MD (deceased), who contributed on earlier versions of this topic and was a founding Editor-in-Chief for UpToDate in Infectious Diseases.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Gray BM, Musher DM. The history of pneumococcal disease. In: Pneumococcal Vaccines: The Impact of Conjugate Vaccine, Siber GR , Klugman KP, Makela PH (Eds), ASM Press, Washington, DC 2008. p.3.</li><li><a class="nounderline abstract_t">Lingappa JR, Dumitrescu L, Zimmer SM, et al. Identifying host genetic risk factors in the context of public health surveillance for invasive pneumococcal disease. PLoS One 2011; 6:e23413.</a></li><li><a class="nounderline abstract_t">Gladstone RA, Jefferies JM, Faust SN, Clarke SC. Sampling methods for the study of pneumococcal carriage: a systematic review. Vaccine 2012; 30:6738.</a></li><li><a class="nounderline abstract_t">Adler H, Nikolaou E, Gould K, et al. Pneumococcal Colonization in Healthy Adult Research Participants in the Conjugate Vaccine Era, United Kingdom, 2010-2017. J Infect Dis 2019; 219:1989.</a></li><li><a class="nounderline abstract_t">Kim PE, Musher DM, Glezen WP, et al. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis 1996; 22:100.</a></li><li><a class="nounderline abstract_t">Raz R, Elhanan G, Shimoni Z, et al. Pneumococcal bacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin. Israeli Adult Pneumococcal Bacteremia Group. Clin Infect Dis 1997; 24:1164.</a></li><li><a class="nounderline abstract_t">Gray BM, Converse GM 3rd, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980; 142:923.</a></li><li><a class="nounderline abstract_t">Musher DM, Groover JE, Reichler MR, et al. Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. Clin Infect Dis 1997; 24:441.</a></li><li class="breakAll">Heffron R. Pneumonia with Special Reference to Pneumococcus Lobar Pneumonia, The Commonwealth Fund, New York, NY 1939.</li><li><a class="nounderline abstract_t">Breiman RF, Spika JS, Navarro VJ, et al. Pneumococcal bacteremia in Charleston County, South Carolina. A decade later. Arch Intern Med 1990; 150:1401.</a></li><li class="breakAll">Gravenstein J, Musher DM. Pneumococcal polysaccharide vaccines. In: Plotkin’s Vaccines, 7th ed, Plotkin SA, Orenstein WA, Offit PA, Edwards KM (Eds), Elsevier, Philadelphia, PA 2018. p.816.</li><li><a class="nounderline abstract_t">Romero-Steiner S, Musher DM, Cetron MS, et al. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis 1999; 29:281.</a></li><li><a class="nounderline abstract_t">Lee H, Nahm MH, Kim KH. The effect of age on the response to the pneumococcal polysaccharide vaccine. BMC Infect Dis 2010; 10:60.</a></li><li><a class="nounderline abstract_t">Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991; 325:1453.</a></li><li><a class="nounderline abstract_t">Harrison LH, Dwyer DM, Billmann L, et al. Invasive pneumococcal infection in Baltimore, Md: implications for immunization policy. Arch Intern Med 2000; 160:89.</a></li><li><a class="nounderline abstract_t">Nuorti JP, Butler JC, Gelling L, et al. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med 2000; 132:182.</a></li><li><a class="nounderline abstract_t">Kyaw MH, Rose CE Jr, Fry AM, et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis 2005; 192:377.</a></li><li><a class="nounderline abstract_t">Watt JP, O'Brien KL, Benin AL, et al. Risk factors for invasive pneumococcal disease among Navajo adults. Am J Epidemiol 2007; 166:1080.</a></li><li><a class="nounderline abstract_t">Cortese MM, Wolff M, Almeido-Hill J, et al. High incidence rates of invasive pneumococcal disease in the White Mountain Apache population. Arch Intern Med 1992; 152:2277.</a></li><li><a class="nounderline abstract_t">Davidson M, Parkinson AJ, Bulkow LR, et al. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990--ethnic differences and opportunities for prevention. J Infect Dis 1994; 170:368.</a></li><li><a class="nounderline abstract_t">Burton DC, Flannery B, Bennett NM, et al. Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. Am J Public Health 2010; 100:1904.</a></li><li><a class="nounderline abstract_t">Austrian R. The Jeremiah Metzger Lecture: Of gold and pneumococci: a history of pneumococcal vaccines in South Africa. Trans Am Clin Climatol Assoc 1978; 89:141.</a></li><li><a class="nounderline abstract_t">HODGES RG, MacLEOD CM. Epidemic pneumococcal pneumonia; description of the epidemic. Am J Hyg 1946; 44:183.</a></li><li><a class="nounderline abstract_t">HODGES RG, MacLEOD CM. Epidemic pneumococcal pneumonia; the influence of population characteristics and environment. Am J Hyg 1946; 44:193.</a></li><li><a class="nounderline abstract_t">Hoge CW, Reichler MR, Dominguez EA, et al. An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med 1994; 331:643.</a></li><li><a class="nounderline abstract_t">Mercat A, Nguyen J, Dautzenberg B. An outbreak of pneumococcal pneumonia in two men's shelters. Chest 1991; 99:147.</a></li><li><a class="nounderline abstract_t">Plevneshi A, Svoboda T, Armstrong I, et al. Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto. PLoS One 2009; 4:e7255.</a></li><li><a class="nounderline abstract_t">Twomey JJ. Infections complicating multiple myeloma and chronic lymphocytic leukemia. Arch Intern Med 1973; 132:562.</a></li><li><a class="nounderline abstract_t">Savage DG, Lindenbaum J, Garrett TJ. Biphasic pattern of bacterial infection in multiple myeloma. Ann Intern Med 1982; 96:47.</a></li><li><a class="nounderline abstract_t">Redd SC, Rutherford GW 3rd, Sande MA, et al. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis 1990; 162:1012.</a></li><li><a class="nounderline abstract_t">Marcus JL, Baxter R, Leyden WA, et al. Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System. AIDS Patient Care STDS 2016; 30:463.</a></li><li><a class="nounderline abstract_t">Ridda I, Macintyre CR, Lindley R, et al. Immunological responses to pneumococcal vaccine in frail older people. Vaccine 2009; 27:1628.</a></li><li><a class="nounderline abstract_t">Torres A, Blasi F, Dartois N, Akova M. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Thorax 2015; 70:984.</a></li><li><a class="nounderline abstract_t">van Hoek AJ, Andrews N, Waight PA, et al. The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England. J Infect 2012; 65:17.</a></li><li><a class="nounderline abstract_t">Thomsen RW, Hundborg HH, Lervang HH, et al. Diabetes and outcome of community-acquired pneumococcal bacteremia: a 10-year population-based cohort study. Diabetes Care 2004; 27:70.</a></li><li><a class="nounderline abstract_t">Garrouste-Orgeas M, Azoulay E, Ruckly S, et al. Diabetes was the only comorbid condition associated with mortality of invasive pneumococcal infection in ICU patients: a multicenter observational study from the Outcomerea research group. Infection 2018; 46:669.</a></li><li><a class="nounderline abstract_t">Bhatty M, Pruett SB, Swiatlo E, Nanduri B. Alcohol abuse and Streptococcus pneumoniae infections: consideration of virulence factors and impaired immune responses. Alcohol 2011; 45:523.</a></li><li><a class="nounderline abstract_t">Theilacker C, Ludewig K, Serr A, et al. Overwhelming Postsplenectomy Infection: A Prospective Multicenter Cohort Study. Clin Infect Dis 2016; 62:871.</a></li><li><a class="nounderline abstract_t">Marrie TJ, Tyrrell GJ, Majumdar SR, Eurich DT. Asplenic patients and invasive pneumococcal disease-how bad is it these days? Int J Infect Dis 2016; 51:27.</a></li><li><a class="nounderline abstract_t">Schurder J, Goulenok T, Jouenne R, et al. Pneumococcal infection in patients with systemic lupus erythematosus. Joint Bone Spine 2018; 85:333.</a></li><li><a class="nounderline abstract_t">Shigayeva A, Rudnick W, Green K, et al. Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs. Clin Infect Dis 2016; 62:139.</a></li><li><a class="nounderline abstract_t">Rueda AM, Serpa JA, Matloobi M, et al. The spectrum of invasive pneumococcal disease at an adult tertiary care hospital in the early 21st century. Medicine (Baltimore) 2010; 89:331.</a></li><li><a class="nounderline abstract_t">Said MA, Johnson HL, Nonyane BA, et al. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One 2013; 8:e60273.</a></li><li><a class="nounderline abstract_t">Musher DM, Alexandraki I, Graviss EA, et al. Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore) 2000; 79:210.</a></li><li><a class="nounderline abstract_t">Marrie TJ, Low DE, De Carolis E, Canadian Community-Acquired Pneumonia Investigators. A comparison of bacteremic pneumococcal pneumonia with nonbacteremic community-acquired pneumonia of any etiology--results from a Canadian multicentre study. Can Respir J 2003; 10:368.</a></li><li><a class="nounderline abstract_t">Bordon JM, Fernandez-Botran R, Wiemken TL, et al. Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response. Infection 2015; 43:729.</a></li><li><a class="nounderline abstract_t">Sandvall B, Rueda AM, Musher DM. Long-term survival following pneumococcal pneumonia. Clin Infect Dis 2013; 56:1145.</a></li><li><a class="nounderline abstract_t">Ajayi OO, Norton NB, Gress TW, et al. Three Decades of Follow-up of Adults After Recovery From Invasive Pneumococcal Pneumonia. Am J Med Sci 2017; 353:445.</a></li><li><a class="nounderline abstract_t">Ort S, Ryan JL, Barden G, D'Esopo N. Pneumococcal pneumonia in hospitalized patients. Clinical and radiological presentations. JAMA 1983; 249:214.</a></li><li><a class="nounderline abstract_t">Watanakunakorn C, Bailey TA. Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996. A detailed analysis of 108 cases. Arch Intern Med 1997; 157:1965.</a></li><li><a class="nounderline abstract_t">Gardner JG, Bhamidipati DR, Rueda AM, et al. White Blood Cell Counts, Alcoholism, and Cirrhosis in Pneumococcal Pneumonia. Open Forum Infect Dis 2017; 4:ofx034.</a></li><li><a class="nounderline abstract_t">Bijlsma MW, Brouwer MC, Kasanmoentalib ES, et al. Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study. Lancet Infect Dis 2016; 16:339.</a></li><li><a class="nounderline abstract_t">van Ettekoven CN, van de Beek D, Brouwer MC. Update on community-acquired bacterial meningitis: guidance and challenges. Clin Microbiol Infect 2017; 23:601.</a></li><li><a class="nounderline abstract_t">Feldman WE. Relation of concentrations of bacteria and bacterial antigen in cerebrospinal fluid to prognosis in patients with bacterial meningitis. N Engl J Med 1977; 296:433.</a></li><li><a class="nounderline abstract_t">Dunbar SA, Eason RA, Musher DM, Clarridge JE 3rd. Microscopic examination and broth culture of cerebrospinal fluid in diagnosis of meningitis. J Clin Microbiol 1998; 36:1617.</a></li><li><a class="nounderline abstract_t">Dugi DD 3rd, Musher DM, Clarridge JE 3rd, Kimbrough R. Intraabdominal infection due to Streptococcus pneumoniae. Medicine (Baltimore) 2001; 80:236.</a></li><li><a class="nounderline abstract_t">Petti CA, Ignatius Ou SH, Sexton DJ. Acute terminal ileitis associated with pneumococcal bacteremia: case report and review of pneumococcal gastrointestinal diseases. Clin Infect Dis 2002; 34:E50.</a></li><li><a class="nounderline abstract_t">Rahav G, Ben-David L, Persitz E. Postmenopausal pneumococcal tubo-ovarian abscess. Rev Infect Dis 1991; 13:896.</a></li><li><a class="nounderline abstract_t">Robinson EN Jr. Pneumococcal endometritis and neonatal sepsis. Rev Infect Dis 1990; 12:799.</a></li><li><a class="nounderline abstract_t">Westh H, Skibsted L, Korner B. Streptococcus pneumoniae infections of the female genital tract and in the newborn child. Rev Infect Dis 1990; 12:416.</a></li><li><a class="nounderline abstract_t">Marrie TJ, Tyrrell GJ, Majumdar SR, Eurich DT. Rates of, and risk factors for, septic arthritis in patients with invasive pneumococcal disease: prospective cohort study. BMC Infect Dis 2017; 17:680.</a></li><li><a class="nounderline abstract_t">Dernoncourt A, El Samad Y, Schmidt J, et al. Case Studies and Literature Review of Pneumococcal Septic Arthritis in Adults. Emerg Infect Dis 2019; 25.</a></li><li><a class="nounderline abstract_t">Ross JJ, Saltzman CL, Carling P, Shapiro DS. Pneumococcal septic arthritis: review of 190 cases. Clin Infect Dis 2003; 36:319.</a></li><li><a class="nounderline abstract_t">Morley PK, Hull RG, Hall MA. Pneumococcal septic arthritis in rheumatoid arthritis. Ann Rheum Dis 1987; 46:482.</a></li><li><a class="nounderline abstract_t">Ryczak M, Sands M, Brown RB, Sklar JH. Pneumococcal arthritis in a prosthetic knee. A case report and review of the literature. Clin Orthop Relat Res 1987; :224.</a></li><li><a class="nounderline abstract_t">Suzuki H, Shichi D, Tokuda Y, et al. Pneumococcal vertebral osteomyelitis at three teaching hospitals in Japan, 2003-2011: analysis of 14 cases and a review of the literature. BMC Infect Dis 2013; 13:525.</a></li><li><a class="nounderline abstract_t">Lindberg J, Prag J, Schønheyder HC. Pneumococcal endocarditis is not just a disease of the past: an analysis of 16 cases diagnosed in Denmark 1986-1997. Scand J Infect Dis 1998; 30:469.</a></li><li><a class="nounderline abstract_t">Lefort A, Mainardi JL, Selton-Suty C, et al. Streptococcus pneumoniae endocarditis in adults. A multicenter study in France in the era of penicillin resistance (1991-1998). The Pneumococcal Endocarditis Study Group. Medicine (Baltimore) 2000; 79:327.</a></li><li><a class="nounderline abstract_t">Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 49-1990. A 47-year-old Cape Verdean man with pericardial disease. N Engl J Med 1990; 323:1614.</a></li><li><a class="nounderline abstract_t">Patel H, Patel C, Soni M, et al. Acute Primary Pneumococcal Purulent Pericarditis With Cardiac Tamponade: A Case Report and Literature Review. Medicine (Baltimore) 2015; 94:e1709.</a></li><li><a class="nounderline abstract_t">Turner DP, Weston VC, Ispahani P. Streptococcus pneumoniae spinal infection in Nottingham, United Kingdom: not a rare event. Clin Infect Dis 1999; 28:873.</a></li><li><a class="nounderline abstract_t">Grigoriadis E, Gold WL. Pyogenic brain abscess caused by Streptococcus pneumoniae: case report and review. Clin Infect Dis 1997; 25:1108.</a></li><li><a class="nounderline abstract_t">Peters NS, Eykyn SJ, Rudd AG. Pneumococcal cellulitis: a rare manifestation of pneumococcaemia in adults. J Infect 1989; 19:57.</a></li><li><a class="nounderline abstract_t">DiNubile MJ, Albornoz MA, Stumacher RJ, et al. Pneumococcal soft-tissue infections: possible association with connective tissue diseases. J Infect Dis 1991; 163:897.</a></li><li><a class="nounderline abstract_t">Capdevila O, Grau I, Vadillo M, et al. Bacteremic pneumococcal cellulitis compared with bacteremic cellulitis caused by Staphylococcus aureus and Streptococcus pyogenes. Eur J Clin Microbiol Infect Dis 2003; 22:337.</a></li><li><a class="nounderline abstract_t">Leeming JP, Cartwright K, Morris R, et al. Diagnosis of invasive pneumococcal infection by serotype-specific urinary antigen detection. J Clin Microbiol 2005; 43:4972.</a></li><li><a class="nounderline abstract_t">Avni T, Mansur N, Leibovici L, Paul M. PCR using blood for diagnosis of invasive pneumococcal disease: systematic review and meta-analysis. J Clin Microbiol 2010; 48:489.</a></li><li><a class="nounderline abstract_t">Moïsi JC, Moore M, Carvalho MDG, et al. Enhanced Diagnosis of Pneumococcal Bacteremia Using Antigen- and Molecular-Based Tools on Blood Specimens in Mali and Thailand: A Prospective Surveillance Study. Am J Trop Med Hyg 2016; 94:267.</a></li><li><a class="nounderline abstract_t">Ramirez JA, Bordon J. Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia. Arch Intern Med 2001; 161:848.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Pneumococcal disease. https://www.cdc.gov/pneumococcal/clinicians/clinical-features.html (Accessed on January 04, 2023).</li><li><a class="nounderline abstract_t">Chen H, Matsumoto H, Horita N, et al. Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis. Sci Rep 2021; 11:11865.</a></li><li><a class="nounderline abstract_t">Versluys KA, Eurich DT, Marrie TJ, Tyrrell GJ. Invasive Pneumococcal Disease and Long-Term Mortality Rates in Adults, Alberta, Canada. Emerg Infect Dis 2022; 28:1615.</a></li><li><a class="nounderline abstract_t">Heo JY, Seo YB, Choi WS, et al. Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis. PLoS One 2018; 13:e0194598.</a></li><li><a class="nounderline abstract_t">De Miguel S, Latasa P, Yuste J, et al. Age-Dependent Serotype-Associated Case-Fatality Rate in Invasive Pneumococcal Disease in the Autonomous Community of Madrid between 2007 and 2020. Microorganisms 2021; 9.</a></li><li><a class="nounderline abstract_t">Müller A, Kleynhans J, de Gouveia L, et al. Streptococcus pneumoniae Serotypes Associated with Death, South Africa, 2012-2018. Emerg Infect Dis 2022; 28:166.</a></li><li><a class="nounderline abstract_t">DiNardo AR, Netea MG, Musher DM. Postinfectious Epigenetic Immune Modifications - A Double-Edged Sword. N Engl J Med 2021; 384:261.</a></li><li><a class="nounderline abstract_t">Raad J, Peacock JE Jr. Septic arthritis in the adult caused by Streptococcus pneumoniae: a report of 4 cases and review of the literature. Semin Arthritis Rheum 2004; 34:559.</a></li></ol></div><div id="topicVersionRevision">Topic 3168 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Gray BM, Musher DM. The history of pneumococcal disease. In: Pneumococcal Vaccines: The Impact of Conjugate Vaccine, Siber GR , Klugman KP, Makela PH (Eds), ASM Press, Washington, DC 2008. p.3.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21858107" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Identifying host genetic risk factors in the context of public health surveillance for invasive pneumococcal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22981760" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Sampling methods for the study of pneumococcal carriage: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30690468" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Pneumococcal Colonization in Healthy Adult Research Participants in the Conjugate Vaccine Era, United Kingdom, 2010-2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8824973" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9195076" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Pneumococcal bacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin. Israeli Adult Pneumococcal Bacteremia Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7462701" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9114197" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9114197" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2369239" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Pneumococcal bacteremia in Charleston County, South Carolina. A decade later.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2369239" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Pneumococcal bacteremia in Charleston County, South Carolina. A decade later.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10476727" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20219110" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The effect of age on the response to the pneumococcal polysaccharide vaccine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1944423" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10632309" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Invasive pneumococcal infection in Baltimore, Md: implications for immunization policy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10651598" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15995950" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17693393" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Risk factors for invasive pneumococcal disease among Navajo adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1444688" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : High incidence rates of invasive pneumococcal disease in the White Mountain Apache population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8035023" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990--ethnic differences and opportunities for prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20724687" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30204" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The Jeremiah Metzger Lecture: Of gold and pneumococci: a history of pneumococcal vaccines in South Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21003015" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Epidemic pneumococcal pneumonia; description of the epidemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21003016" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Epidemic pneumococcal pneumonia; the influence of population characteristics and environment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8052273" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1984946" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : An outbreak of pneumococcal pneumonia in two men's shelters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19787070" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4542660" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Infections complicating multiple myeloma and chronic lymphocytic leukemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6976144" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Biphasic pattern of bacterial infection in multiple myeloma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2230229" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27749111" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19100304" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Immunological responses to pneumococcal vaccine in frail older people.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26219979" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22394683" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14693969" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Diabetes and outcome of community-acquired pneumococcal bacteremia: a 10-year population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29974388" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Diabetes was the only comorbid condition associated with mortality of invasive pneumococcal infection in ICU patients: a multicenter observational study from the Outcomerea research group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21827928" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Alcohol abuse and Streptococcus pneumoniae infections: consideration of virulence factors and impaired immune responses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26703862" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Overwhelming Postsplenectomy Infection: A Prospective Multicenter Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27590561" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Asplenic patients and invasive pneumococcal disease-how bad is it these days?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28529115" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Pneumococcal infection in patients with systemic lupus erythematosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26354970" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20827110" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The spectrum of invasive pneumococcal disease at an adult tertiary care hospital in the early 21st century.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23565216" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10941350" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14571288" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : A comparison of bacteremic pneumococcal pneumonia with nonbacteremic community-acquired pneumonia of any etiology--results from a Canadian multicentre study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26424683" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23300240" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Long-term survival following pneumococcal pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28502330" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Three Decades of Follow-up of Adults After Recovery From Invasive Pneumococcal Pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6848806" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Pneumococcal pneumonia in hospitalized patients. Clinical and radiological presentations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9308508" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996. A detailed analysis of 108 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28730156" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : White Blood Cell Counts, Alcoholism, and Cirrhosis in Pneumococcal Pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26652862" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28478238" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Update on community-acquired bacterial meningitis: guidance and challenges.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13301" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Relation of concentrations of bacteria and bacterial antigen in cerebrospinal fluid to prognosis in patients with bacterial meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9620388" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Microscopic examination and broth culture of cerebrospinal fluid in diagnosis of meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11470984" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Intraabdominal infection due to Streptococcus pneumoniae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11981747" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Acute terminal ileitis associated with pneumococcal bacteremia: case report and review of pneumococcal gastrointestinal diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1962105" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Postmenopausal pneumococcal tubo-ovarian abscess.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2237119" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Pneumococcal endometritis and neonatal sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2193349" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Streptococcus pneumoniae infections of the female genital tract and in the newborn child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29025402" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Rates of, and risk factors for, septic arthritis in patients with invasive pneumococcal disease: prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31538930" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Case Studies and Literature Review of Pneumococcal Septic Arthritis in Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12539074" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Pneumococcal septic arthritis: review of 190 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3632070" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Pneumococcal septic arthritis in rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3665244" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Pneumococcal arthritis in a prosthetic knee. A case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24209735" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Pneumococcal vertebral osteomyelitis at three teaching hospitals in Japan, 2003-2011: analysis of 14 cases and a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10066046" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Pneumococcal endocarditis is not just a disease of the past: an analysis of 16 cases diagnosed in Denmark 1986-1997.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11039081" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Streptococcus pneumoniae endocarditis in adults. A multicenter study in France in the era of penicillin resistance (1991-1998). The Pneumococcal Endocarditis Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2233951" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 49-1990. A 47-year-old Cape Verdean man with pericardial disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26469910" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Acute Primary Pneumococcal Purulent Pericarditis With Cardiac Tamponade: A Case Report and Literature Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10825053" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Streptococcus pneumoniae spinal infection in Nottingham, United Kingdom: not a rare event.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9402366" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Pyogenic brain abscess caused by Streptococcus pneumoniae: case report and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2674295" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Pneumococcal cellulitis: a rare manifestation of pneumococcaemia in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2010644" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Pneumococcal soft-tissue infections: possible association with connective tissue diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12783279" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Bacteremic pneumococcal cellulitis compared with bacteremic cellulitis caused by Staphylococcus aureus and Streptococcus pyogenes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16207950" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Diagnosis of invasive pneumococcal infection by serotype-specific urinary antigen detection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20007385" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : PCR using blood for diagnosis of invasive pneumococcal disease: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26643535" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Enhanced Diagnosis of Pneumococcal Bacteremia Using Antigen- and Molecular-Based Tools on Blood Specimens in Mali and Thailand: A Prospective Surveillance Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11268227" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11268227" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34088948" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35876489" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Invasive Pneumococcal Disease and Long-Term Mortality Rates in Adults, Alberta, Canada.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29596444" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34835413" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Age-Dependent Serotype-Associated Case-Fatality Rate in Invasive Pneumococcal Disease in the Autonomous Community of Madrid between 2007 and 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34932448" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Streptococcus pneumoniae Serotypes Associated with Death, South Africa, 2012-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33471978" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Postinfectious Epigenetic Immune Modifications - A Double-Edged Sword.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15505773" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Septic arthritis in the adult caused by Streptococcus pneumoniae: a report of 4 cases and review of the literature.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
